Caption Management, LLC Dbv Technologies S.A. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.75 - $6.57 $662,274 - $1.58 Million	-240,827 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.38 - $3.01 $332,341 - $724,889	240,827 New	240,827 $631,000
Q2 2018 Aug 14, 2018	SELL	$18.6 - $24.94 $465,000 - $623,500	-25,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.86 - $26.6 $521,500 - $665,000	25,000 New	25,000 $576,000

37.7M

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $175M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.